ConductScience.org, home

Paper33338115

What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden.

Cardoso CRB and 2 others. Rev Soc Bras Med Trop, 2020. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden. Papers, record 33338115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33338115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden.
PubMed
Journal
Rev Soc Bras Med Trop
PubMed
Year
2020
PubMed
Publication types
Letter, Comment
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2021-01-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cardoso CRBCristina Ribeiro de Barroshttps://orcid.org/0000-0002-6156-3144
2Fernandes APMAna Paula Morais
3Santos IKFMIsabel Kinney Ferreira de Miranda

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
PandemicsMajor topic
Brazil
Communication
Cost of Illness
Humans
SARS-CoV-2

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on32491108COVID-19: challenges for a new epoch.https://conductscience.org/library/papers/32491108

Source PubMed

Download CSV of comments and corrections

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131491384Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.Cell2019https://conductscience.org/library/papers/31491384PubMed
232491096Health belief model for coronavirus infection risk determinants.Rev Saude Publica2020https://conductscience.org/library/papers/32491096PubMed
332730103The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay.Hum Vaccin Immunother2020https://conductscience.org/library/papers/32730103PubMed
432849619Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.Front Immunol2020https://conductscience.org/library/papers/32849619PubMed
532965456Evidence, rationality, and ignorance: Agnotological issues in COVID-19 science.Rev Soc Bras Med Trop2020https://conductscience.org/library/papers/32965456PubMed
631551570Antibiotics can impede flu vaccines.Nat Rev Immunol2019https://conductscience.org/library/papers/31551570PubMed
732251768The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.Antiviral Res2020https://conductscience.org/library/papers/32251768PubMed
832491108COVID-19: challenges for a new epoch.Rev Soc Bras Med Trop2020https://conductscience.org/library/papers/32491108PubMed
932379955Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.N Engl J Med2020https://conductscience.org/library/papers/32379955PubMed
1033111916Lockdown as an Intervention Measure to Mitigate the Spread of COVID-19: a modeling study.Rev Soc Bras Med Trop2020https://conductscience.org/library/papers/33111916PubMed
1132320998COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases.Rev Soc Bras Med Trop2020https://conductscience.org/library/papers/32320998PubMed
1232897661Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.N Engl J Med2020https://conductscience.org/library/papers/32897661PubMed
1333111917Brazil: the emerging epicenter of COVID-19 pandemic.Rev Soc Bras Med Trop2020https://conductscience.org/library/papers/33111917PubMed
1432392282Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.JAMA2020https://conductscience.org/library/papers/32392282PubMed
1526465669Educational inequality in the occurrence of abdominal obesity:Pró-Saúde Study.Rev Saude Publica2015https://conductscience.org/library/papers/26465669PubMed
1630007544Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota.Int J Parasitol Drugs Drug Resist2018https://conductscience.org/library/papers/30007544PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
37152194Lessons learned from the impact of the COVID-19 pandemic in Brazil on primary-care workplace learning groups.J Res Nurs2023https://conductscience.org/library/papers/37152194PubMed
35324951Analysis of the impact of coronavirus disease 19 on hospitalization rates for chronic non-communicable diseases in Brazil.PLoS One2022https://conductscience.org/library/papers/35324951PubMed
35299698Ivermectin and the Integrity of Healthcare Evidence During COVID-19.Front Public Health2022https://conductscience.org/library/papers/35299698PubMed
35061811COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil.PLoS One2022https://conductscience.org/library/papers/35061811PubMed
34672323Dynamics of social corrections to peers sharing COVID-19 misinformation on WhatsApp in Brazil.J Am Med Inform Assoc2021https://conductscience.org/library/papers/34672323PubMed
34406894Impact of COVID-19 Pandemic on Cancer-Related Hospitalizations in Brazil.Cancer Control2021https://conductscience.org/library/papers/34406894PubMed
34036254Urgent needs to accelerate the race for COVID-19 therapeutics.EClinicalMedicine2021https://conductscience.org/library/papers/34036254PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33338115

GET https://conductscience.org/api/papers/v1/33338115/authors